本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sonnet BioTherapeutics Holdings, Inc.

1.26
0.0000
成交量:- -
成交額:- -
市值:891.81萬
市盈率:-0.25
高:1.26
開:1.26
低:1.26
收:1.26
52周最高:7.90
52周最低:1.26
股本:707.79萬
流通股本:680.21萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-5.0074
每股收益(LYR):-11.3504
淨資產收益率:-310.85%
總資產收益率:-112.17%
市淨率:0.83
市盈率(LYR):-0.11

資料載入中...

2023/10/24

SEC問詢函

Form CORRESP - Correspondence
2023/10/20

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/29

SEC問詢函

Form CORRESP - Correspondence
2023/09/29

SEC問詢函

Form CORRESP - Correspondence
2023/09/28

SEC問詢函

Form CORRESP - Correspondence
2023/09/28

SEC問詢函

Form CORRESP - Correspondence
2023/09/28

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/20

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/09/19

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/22

重要事件披露

Form 8-K - Current report
2023/08/21

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/07

SEC問詢函

Form CORRESP - Correspondence
2023/07/28

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/07/21

重要事件披露

Form 8-K - Current report